Cognitive$40–$65

NA-Selank Amidate: Dosage, Benefits & Side Effects

By Peptide Assistant Editorial Team · · · 15 sources cited

Overview

N-Acetyl Selank Amidate is an enhanced version of Selank, a synthetic heptapeptide analog of the naturally occurring immunomodulatory peptide tuftsin. The N-acetyl and amide modifications are meant to improve its stability, half-life and blood-brain barrier penetration, but none of these has been measured for the modified peptide in any published study. It is primarily used as an anxiolytic nootropic, providing calm focus without sedation, and has immunomodulatory properties that distinguish it from conventional anxiolytic drugs.

Mechanism of Action

NA-Selank Amidate modulates multiple neurotransmitter systems simultaneously. Its primary anxiolytic mechanism involves allosteric modulation of GABA-A receptors, enhancing GABAergic inhibitory tone, and in animal tests without the sedation benzodiazepines cause, while dependence has not been studied. It also stabilizes enkephalin levels by inhibiting enkephalinase, prolonging the activity of these endogenous opioid peptides involved in stress resilience and mood regulation. Additionally, it influences serotonin metabolism, modulating the balance of 5-HT and its metabolites in the hippocampus and frontal cortex. The immunomodulatory effects are attributed to its tuftsin backbone: in patients it suppressed IL-6 gene expression in blood cells while raising IL-6 in their cell cultures, and it shifted the balance of Th1 and Th2 cytokines. Selank itself is detectable in rat plasma for only 7 to 10 minutes; what the N-acetyl and amide modifications do to that has not been published.

NA-Selank Amidate Benefits: What the Research Shows

  • Seredenin et al. (1998) in Zhurnal Vysshei Nervnoi Deiatelnosti showed the Selank heptapeptide prevented anxiety in the elevated plus maze in BALB/c mice, comparable to low doses of benzodiazepines but with no inhibitory behavioural effects even at high doses
  • Russian clinical studies compared Selank with benzodiazepines in generalized anxiety disorder, neurasthenia and somatoform disorders, and it is used in Russia as an anxiolytic
  • Research in Regulatory Peptides (2011) showed Selank changed the expression of 34 of 84 inflammation-related genes in mouse spleen
  • Kozlovskii and Danchev (2003) showed Selank improved conditioned active avoidance learning in rats, most clearly in animals that learned poorly to begin with
  • A study showed Selank lengthened the half-life of plasma leu-enkephalin in anxious BALB/c mice alongside its anxiolytic effect, supporting the enkephalin mechanism (Bulletin of Experimental Biology and Medicine, 2002)
  • Preclinical research showed Selank suppressed influenza A virus reproduction in cell culture and improved survival of infected mice, through interferon and cytokine effects

NA-Selank Amidate Dosage

  • Intranasal: 200–600 mcg per nostril, 1–3 times daily
  • Subcutaneous: 250–750 mcg once or twice daily
  • Start with 200 mcg intranasally to assess response
  • Can be used situationally for acute anxiety or daily for sustained anxiolytic effects
  • Cycle: 2–4 weeks on, 1–2 weeks off, though some use continuously for longer periods
  • Best stacked with NA-Semax Amidate for balanced stimulation and calm
  • Effects onset within 10–20 minutes intranasally
Peptide calculator: get your dose in syringe units →

Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.

NA-Selank Amidate Side Effects & Safety

Known Side Effects

  • Nasal irritation — mild dryness or tingling when used intranasally, usually diminishes with continued use
  • Fatigue — some users report mild drowsiness, particularly at higher doses or when combined with other GABAergic substances
  • Headache — infrequently reported, generally mild and self-resolving
  • Emotional blunting — rarely, some users report reduced emotional intensity at higher doses, suggesting over-modulation of limbic activity
  • No dependence, withdrawal or tolerance has been reported, though the published trials were small and short and none set out to test for it

Safety Profile

Selank has been used in Russia since the early 2000s for anxiety and neurasthenia, but its published safety record is three small trials of 60 to 70 patients each. Physical dependence, tolerance and withdrawal have not been tested for in any published study. There is no evidence of sedation-related cognitive impairment at standard doses. The immunomodulatory effects are generally beneficial but individuals with autoimmune conditions should exercise caution. Drug interactions have not been studied in people; in animals Selank altered the effects of both diazepam and ethanol, so combining it with alcohol or sedatives is untested ground. The NA-Selank Amidate form has no published studies of any kind, so its pharmacology and stability are assumed from the parent compound rather than measured.

What to Expect

Within 10–20 minutes (intranasal): A subtle but noticeable reduction in background anxiety and mental tension. Users describe a 'calm clarity' without sedation or cognitive dulling. Days 1–3: Anxiolytic effects are consistent and reliable with each dose. Social interactions feel easier, stress tolerance improves, and rumination decreases. Week 1–2: Cumulative benefits emerge — improved stress resilience, better emotional regulation, and enhanced ability to focus under pressure. Sleep quality often improves as evening anxiety decreases. Weeks 3–4: Peak anxiolytic and immunomodulatory effects. Users report a stable, calm baseline mood with improved cognitive performance. After cessation, there is no withdrawal — effects fade gradually over 3–7 days.

Common Stacks

Storage & Handling

Store lyophilized powder at -20°C for long-term storage or 2–8°C for up to 6 months. Nasal spray solutions should be refrigerated and used within 3–4 weeks after preparation. Reconstitute with bacteriostatic water or sterile saline. The N-acetyl amide modifications provide significantly improved stability compared to standard Selank. Protect from light and avoid repeated freeze-thaw cycles.

Pricing & Available Variants

$40 – $65price range
10mg30mg

Prices sourced from peptides.gg marketplace. Prices may vary.

References

  1. Zozulia AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008.
  2. Medvedev VE, Tereshchenko ON, Israelian AIu, et al. A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2014.
  3. Vyunova TV, Andreeva L, Shevchenko K, et al. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein Pept Lett. 2018.
  4. Zozulya AA, Kost NV, Yu Sokolov O, et al. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bull Exp Biol Med. 2001.
  5. Sokolov OY, Meshavkin VK, Kost NV, et al. Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions. Bull Exp Biol Med. 2002.
  6. Seredenin SB, Kozlovskaia MM, Blednov IuA, et al. The anxiolytic action of an analog of the endogenous peptide tuftsin on inbred mice with different phenotypes of the emotional stress reaction. Zh Vyssh Nerv Deiat Im I P Pavlova. 1998.
  7. Kozlovskii II, Danchev ND. The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in rats. Neurosci Behav Physiol. 2003.
  8. Kolomin T, Shadrina M, Andreeva L, et al. Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank. Regul Pept. 2011.
  9. Uchakina ON, Uchakin PN, Miasoedov NF, et al. Immunomodulatory effects of selank in patients with anxiety-asthenic disorders. Zh Nevrol Psikhiatr Im S S Korsakova. 2008.
  10. Ershov FI, Uchakin PN, Uchakina ON, et al. Antiviral activity of immunomodulator Selank in experimental influenza infection. Vopr Virusol. 2009.
  11. Boĭko SS, Zherdev VP, Dvorianinov AA, et al. The pharmacokinetics and metabolism of heptapeptide--a prospective synthetic analog of tuftsin with psychostimulating action in rats. Eksp Klin Farmakol. 1998.
  12. Kasian A, Kolomin T, Andreeva L, et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol. 2017.
  13. Kolik LG, Nadorova AV, Seredenin SB. Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice. Bull Exp Biol Med. 2016.
  14. Doyno CR, White CM. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank. J Clin Pharmacol. 2021.
  15. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. U.S. Food and Drug Administration. 2026.

Related Peptides

Track NA-Selank Amidate in Your Protocol

Log your NA-Selank Amidate doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.

Start Tracking Free